June 25, 2026
In this issue:
The Improving Patient Care Through NCDB session will highlight how the National Cancer Database® (NCDB®) can support data-driven decision making through robust reports and tools. Attendees at the 2026 ACS Quality, Safety & Cancer Conference (QSCC), July 30–August 2 in Orlando, Florida, will learn how to access, interpret, and apply NCDB data to identify opportunities and drive measurable improvements in care.
Presenters at another QSCC session, Value through Accreditation: Examples from Cancer Programs, will discuss how accredited programs can meet standards while realizing both tangible and intangible benefits. Attendees will gain real-world examples that highlight how accreditation supports quality, performance, and program growth.
Register now to secure your spot and view the program agenda to start planning your QSCC experience.
The US Food and Drug Administration (FDA) has sent a letter to healthcare providers regarding interruptions in the supply of stereotactic breast biopsy needles because of recent supplier issues. According to the FDA, the disruption, which is expected to last through March 2027, may impact patient care and "require adjustments to the clinical management of patients indicated to undergo a breast biopsy."
The Commission on Cancer (CoC) and the Cancer Surgery Standards Program (CSSP) are requesting feedback on five proposed standards revisions:
The revisions to the CoC Operative Standards are focused on decreasing administrative challenges through updated synoptic elements and responses that focus the standards more on intraoperative quality improvement. Clarifications were also included in the operative report requirement and scope of standard sections, as necessary, to incorporate frequently asked questions.
The proposed standards, summary of proposed revisions, and public comment survey may be accessed below:
The CoC and CSSP will promote the proposed standards and survey through communications channels to ensure widespread engagement from the surgical community. CoC- accredited programs are strongly encouraged to share the proposed standards and survey with surgeons who perform breast, colon, and lung cancer operations, pathologists, and any other relevant stakeholders to ensure all affected parties are aware of the changes.
The public comment period ends July 6. The information received during the public comment period will be used to further refine the standards requirements and compliance measures in the proposed standards. The CoC and CSSP are working with the College of American Pathologists Cancer Committee on alignment of standards. It is expected that the revisions will need to be implemented at CoC- accredited cancer programs in January 2028. The CoC and CSSP are working with EHR vendors to integrate the final revisions. An official timeline will be provided once the revisions are finalized.
All questions related to the content of the standards revisions must be submitted through the feedback survey. Questions and feedback provided will not be answered with a direct response, but all feedback will be considered.
A newly launched CoC accreditation program aims to help patients in rural communities close gaps in cancer care and outcomes by providing programs with evidence-based standards, resources, and support to strengthen care delivery and recognize high-quality cancer care closer to home.
The CoC released an updated version of its accreditation standards, Optimal Resources for Cancer Care (2020 Standards), reinforcing its commitment to continuous quality improvement in cancer care. The March 2026 revisions introduce several important enhancements and clarifications designed to support accredited programs. For a comprehensive summary of all revisions, refer to the CoC Standards Changelog. Key updates include:
Standard 4.2: Oncology Nursing Credentials
In addition to the revisions effective on January 1, the March 2026 version of Standard 4.2: Oncology Nursing Credentials adds an option for programs to use an action plan during the annual review if the program is not meeting its policy or Standard 4.2 requirements.
The organization and formatting of the standard were also updated to clarify the existing requirements. No other substantive changes have been made. The implementation timeline for this standard remains the same. The FAQs has been extensively updated to answer common program questions.
Standards 5.1, 5.9, and 7.1
Standards 5.1, 5.9, and 7.1 were updated to clarify that any required action plans are included with the internal audit when presented to the cancer committee and included in cancer committee meeting minutes.
Operative Standards 5.3–5.6
Standards 5.3–5.6 were updated as follows:
Standard 6.1: Cancer Registry Quality Control
The Specifications by Category for Integrated Network Cancer Programs and NCI Networks for Standard 6.1 have been updated. Previous language was subject to multiple interpretations, and as a result, the requirements have been clarified to better accomplish the goals of this standard.
Rural Cancer Program Specifications
The recently released rural cancer program requirements were added to the Specifications by Category section.
Questions on any of these updates may be submitted to the CAnswer Forum.
The Assessing the Effectiveness and Significance of the Operative Standards Program (AESOP) study is a 5-year, multi-institutional initiative funded by the National Cancer Institute. The AESOP team is evaluating how the CoC Operative Standards are implemented and their impact on cancer care. A central component of this work involves collecting insights from CLPs through national surveys.
The Cancer Liaison Physicians (CLPs) at programs undergoing CoC accreditation site visits in July will receive a survey link from REDCap@facs.org. CLPs are asked to complete the 10-to-15-minute survey within 2 weeks of receiving the email. In appreciation for their time, CLPs will receive a $50 gift card upon completion of the survey.
Learn more about the AESOP study in the January issue of the Bulletin of the American College of Surgeons, in which authors discuss the aims and progress of the program.
Contact AESOP@facs.org with any questions.
Cancer Programs on-demand webinars are designed to help healthcare professionals stay informed, improve performance, and enhance patient care. Leading experts review best practices, accreditation guidance, quality improvement strategies, and the latest developments in oncology care. Recently added webinars include:
Contact CancerProgramsEvents@facs.org with any questions.
The ACS CoC recognizes the following cancer sites for demonstrating their commitment to providing high-quality, patient-centered cancer care to patients and the community by recently earning CoC reaccreditation:
Covenant HealthCare
Saginaw, MI
Intermountain Healthcare Cancer Program Network
Murray, UT
MyMichigan Health
Midland, MI
OhioHealth Berger Hospital
Circleville, OH
St. Mark's Hospital
Salt Lake City, UT
The ACS NAPBC recognizes the following breast sites for demonstrating their commitment to providing high-quality, patient-centered cancer care to patients and the community by recently earning NAPBC reaccreditation:
Bayshore Medical Center
Holmdel, NJ
Billings Clinic
Billings, MT
Cambridge Breast Center
Cambridge, MA
Integrated Breast Center
Oxnard, CA
Joanie Abdu Comprehensive Breast Care Center
Youngtown, OH
Multidisciplinary Breast Program of the Carol G. Simon Cancer Center
Summit, NJ
Resurrection Medical Center
Chicago, IL
July 30–August 2: ACS Quality, Safety & Cancer Conference
September 26–29: ACS Clinical Congress 2026